| Jeane Porter Hester | |
| Birth Date: | 15 June 1929 |
| Birth Place: | Big Spring, Texas, U.S. |
| Death Place: | Galveston, Texas, U.S. |
| Workplaces: | University of Texas MD Anderson Cancer Center |
| Alma Mater: | Oklahoma College for Women, Oklahoma City University, University of Oklahoma |
| Thesis1 Title: | and |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Awards: | University of Science and Arts of Oklahoma Hall of Fame, Texas Women's Hall of Fame, Oklahoma Hall of Fame, Cohn de Laval Award |
Jeane Porter Hester (June 15, 1929 – December 24, 2018) was an American physician known for her work in cancer research and therapy.[1] [2] She was a Professor of Medicine, Chief of Supportive Therapy, and Chief of Leukapheresis at University of Texas MD Anderson Cancer Center in Houston, Texas,[3] and was one of the developers of IBM 2997, the computerized blood cell separator.[4] She was inducted into the Texas Women's Hall of Fame in 1984 and the Oklahoma Hall of Fame in 1987.[5]
Jeane Porter was born on June 15, 1929, in Big Spring, Texas.[6] She grew up in Chickasha, Oklahoma.[5] After graduating from Chickasha High School,[5] she attended Oklahoma College for Women in Chickasha, where she majored in French[2] and minored in history and philosophy.[7]
After graduating, she worked for a medical doctor in Chickasha and then as a secretary for an ophthalmologist in Oklahoma City, Dr. Welborn Sanger.[2] Sanger, recognizing her potential talent in the medical field, promoted her to surgical assistant.[2] Sanger encouraged her to complete a medical degree, so she studied in the pre-medical program at Oklahoma City University, graduating in 1963.[2] She was admitted to the University of Oklahoma College of Medicine, from which she graduated in 1967.[2] [5] In 1971, she completed a residency in hematology and oncology, and from 1971 to 1973, she was a fellow in oncology at the University of Texas MD Anderson Cancer Center.[2] Hester then became an assistant professor at MD Anderson, where she worked in cancer hematology research.[2] She rose to the rank of professor and became Chief of Supportive Therapy and Chief of Leukapheresis service.[5] Through the National Heart, Lung, and Blood Institute she worked as an exchange scientist to the Soviet Union.[3]
Hester was one of the developers of IBM 2997, the computerized blood cell separator.[4] [5] [2] The separator is "used in diagnosing red and white blood cells and platelets and the enhancement of cells to combat tumors."[5]
Hester served on the editorial boards of the Journal of Clinical Apheresis, the Journal of the American Medical Association, and Plasma Therapy and Transfusion Technology.[3] She has contributed to over 25 books and over 125 other writings.[8]
Jeane Porter married Bob Hester in 1951, and their son Steven was born in 1953.[6] Jeane Porter Hester died in Galveston, Texas on December 24, 2018, at the age of 89.[9]
Hester was a member of the Oklahoma College for Women Hall of Fame, the Texas Women's Hall of Fame, and the Oklahoma Hall of Fame.[5] She was a recipient of the Cohn de Laval Award for great scientific contributions to apheresis.[10] [4]